Stay updated on Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Sign up to get notified when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Publications related to the study were added and core trial details such as start date, completion date, enrollment, and locations were updated.
    Difference
    0.4%
    Check dated 2025-11-03T21:00:24.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    34 days ago
    Change Detected
    Summary
    Major update: adds current operating status notice and links for NIH Clinical Center, and bumps version to v3.2.0, replacing the old v3.1.0.
    Difference
    4%
    Check dated 2025-10-06T05:23:01.000Z thumbnail image
  4. Check
    41 days ago
    Change Detected
    Summary
    Version update: from v3.0.2 to v3.1.0. The change is limited to the revision label; no core content or critical data appears to be altered.
    Difference
    0.1%
    Check dated 2025-09-29T03:02:38.000Z thumbnail image
  5. Check
    55 days ago
    Change Detected
    Summary
    Updated the page revision from v3.0.1 to v3.0.2 and removed the Back to Top element.
    Difference
    0.2%
    Check dated 2025-09-14T19:02:56.000Z thumbnail image
  6. Check
    62 days ago
    Change Detected
    Summary
    The web page has been updated from version 3.0.0 to version 3.0.1, indicating a revision in the content. There are no significant changes to core content or other important elements.
    Difference
    0.2%
    Check dated 2025-09-07T15:02:27.000Z thumbnail image
  7. Check
    70 days ago
    Change Detected
    Summary
    The web page has been updated to include a new facility name, location details, and a list of publications related to pegcetacoplan treatment for geographic atrophy in age-related macular degeneration. Additionally, the revision number has been updated to v3.0.0.
    Difference
    6%
    Check dated 2025-08-31T11:44:41.000Z thumbnail image

Stay in the know with updates to Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Safety of Intravitreal APL-2 in Geographic Atrophy Clinical Trial page.